Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pennsylvania
Duke University
City of Hope Medical Center
Eli Lilly and Company
Novartis
Dokuz Eylul University
City of Hope Medical Center
AstraZeneca
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
Jonsson Comprehensive Cancer Center
Wake Forest University Health Sciences
Eli Lilly and Company
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver